NCT06488183 Laparoscopic Preperitoneal Local Anesthetic Infiltration Versus Ultrasound Guided Quadratus Lumborum Block in Laparoscopic Bariatric Surgery
| NCT ID | NCT06488183 |
| Status | Recruiting |
| Phase | — |
| Sponsor | sarah mohamed |
| Condition | Pain Management |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2024-05-12 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2024-05-12 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
preperitoneal local anesthetic infiltration is effective for relief of postoperative pain in patients undergoing laparoscopic bariatric surgery.
Eligibility Criteria
Inclusion Criteria: * Age: 20-50 years, both sexes. * ASA physical status class I to III. * BMI 35-50 kg/m² Exclusion Criteria: * Severe cardiac disorder * chronic renal failure * liver cirrhosis * allergy to bupivacaine * patients with history of chronic opioid consumption * HBA1C \> 7%
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06488183 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 50 Years, studying Pain Management. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06488183 currently recruiting?
Yes, NCT06488183 is actively recruiting participants. Contact the research team at sarahelgamal1990@yahoo.com for enrollment information.
Where is the NCT06488183 trial being conducted?
This trial is being conducted at Alexandria, Egypt.
Who is sponsoring the NCT06488183 clinical trial?
NCT06488183 is sponsored by sarah mohamed. The trial plans to enroll 44 participants.